Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes

Front Psychiatry. 2022 Mar 23:13:877390. doi: 10.3389/fpsyt.2022.877390. eCollection 2022.

¹ Burden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
² School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
³ YourCareChoice, Ann Arbor, MI, United States.
⁴ Acumen Health Research Institute, Ann Arbor, MI, United States.
⁵ Biological Psychiatry Laboratory and Hadassah BrainLabs, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.
⁶ Back of the Yards Algae Sciences - Parow Entheobiosciences, Chicago, IL, United States.

Abstract

[This corrects the article DOI: 10.3389/fpsyt.2021.780696.].

Keywords: anxiety; depression; health insurance; healthcare resource utilization; population based survey; psilocybin mushroom; psychedelic.